<?xml version="1.0" encoding="UTF-8"?>
<p id="par0045">In this article we provide an overview of the complex interaction between CoV and the immune system, and analyze similarities and differences among the three CoV (SARS-CoV, MERS-CoV, and SARS-CoV-2). We also suggest practical indications to guide decision-making, in view of the available data on COVID-19 diffusion risk in the oncologic population, with specific considerations for patients receiving immunotherapy.</p>
